Clarity Pharmaceuticals (ASX:CU6)
ASX announcement history & article coverage
Transparent by design.
Announcments by Clarity Pharmaceuticals (ASX:CU6) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Ceasing to be a substantial holder
Becoming a substantial holder
Ceasing to be a substantial holder
Bioshares Biotech Summit Presentation
Clarity Pharmaceuticals showcases superior prostate cancer imaging and therapy candidates with strong clinical data and market potential
Becoming a substantial holder
Notification regarding unquoted securities - CU6
SECuRE update
Clarity reports strong early efficacy and safety data for 8 GBq 67Cu-SAR-bisPSMA in prostate cancer SECuRE trial
Ceasing to be a substantial holder
Quarterly Activities/Appendix 4C Cash Flow Report
Clarity Pharmaceuticals reports strong cash, advances clinical trials, and secures manufacturing deal for prostate cancer radiopharmaceuticals
Becoming a substantial holder
Initial Director's Interest Notice - Rossiter
Allison Rossiter joins Clarity Board of Directors
Ceasing to be a substantial holder
Ceasing to be a substantial holder
Cleansing Notice
Application for quotation of securities - CU6
Becoming a substantial holder
Data on SAR-bisPSMA to be presented at EANM
Clarity Pharmaceuticals to present promising prostate cancer imaging and therapy data at EANM 2026
Clarity celebrates 100-employee milestone
Ceasing to be a substantial holder
Ceasing to be a substantial holder
Change in substantial holding
Becoming a substantial holder
Notification regarding unquoted securities - CU6
Cleansing Notice
Application for quotation of securities - CU6